Entera Bio ENTX
NASDAQ ENTX
$3.25 +0.03 (+0.93%)
As of: Aug 21, 2026 · 2:58 PM EDT

Entera Bio (ENTX) Operating Margin Growth (1y) (2020 - 2022)

Entera Bio (ENTX) Operating Margin Growth (1y) (2020 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.75 Bn 130.90 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 85.96 Bn 77.96 Bn 3.93 Bn 78.00
3 Argenx Se 64.98 Bn 59.80 Bn 1.37 Bn 1,135.00
4 Moderna 56.33 Bn 51.19 Bn 52.00 Mn 7,666.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 1,238.00
6 Alnylam Pharmaceuticals 31.56 Bn 28.25 Bn 992.69 Mn 2,002.00
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn -3,558.00
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn 29,091.00
9 Royalty Pharma 27.32 Bn 26.49 Bn - -1,651.00
10 Entera Bio 164.09 Mn 152.78 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.94 Mn
Sep 30, 2022 -3.35 Mn
Jun 30, 2022 -502,629.00
Mar 31, 2022 -414,990.00
Jun 30, 2021 442,489.00
Jun 30, 2020 -404,080.00